| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3976751 | Brachytherapy | 2016 | 6 Pages |
Abstract
IPSA does not present any additional risk compared with GO in HDR prostate brachytherapy when catheter uncertainties are taken into account. Moreover, IPSA optimization preserves planning target volume coverage better than GO, suggesting that it may be superior when catheter displacement is considered.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Gabriel Reynés-Llompart, Francisco Pino, Ignasi Modolell, Cristina Gullón, Joan Pera, Cristina Gutierrez, Cristina Picón,